Biomerica (BMRA) Cash from Financing Activities (2010 - 2026)
Biomerica (BMRA) posted Cash from Financing Activities of $61000.0 for Q1 2026, down 87.34% sequentially from $482000.0 in Q4 2025, and down 96.49% YoY from $1.7 million in Q1 2025.
Biomerica (BMRA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Biomerica has reported Cash from Financing Activities for 16 years, with the latest figure at $61000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 96.49% year-over-year to $61000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $1.5 million (down 84.4% YoY) and the FY2025 annual result came in at $2.1 million, up 2706.17% from the prior year.
- Cash from Financing Activities retreated to $61000.0 in Q1 2026 per BMRA's latest filing, from $482000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $7.4 million in Q2 2023 and troughed at -$5000.0 in Q2 2025.
- A 4-year average of $1.2 million and a median of $482000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities soared 19414.14% in 2023, then sank 96.49% in 2026.
- Over 4 years, Cash from Financing Activities stood at $237000.0 in 2022, then jumped by 3001.27% to $7.4 million in 2023, then plunged by 93.44% to $482000.0 in 2025, then sank by 87.34% to $61000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $61000.0, $482000.0, and $920000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 61,000.00 |
| Feb 28, 2026 | 61,000.00 |
| Nov 30, 2025 | 482,000.00 |
| Nov 30, 2025 | 482,000.00 |
| Aug 31, 2025 | 920,000.00 |
| Aug 31, 2025 | 920,000.00 |
| May 31, 2025 | -5,000.00 |
| May 31, 2025 | -5,000.00 |
| Feb 28, 2025 | 1.74 Mn |
| Feb 28, 2025 | 1.74 Mn |
| May 31, 2023 | 7.35 Mn |
| May 31, 2023 | 7.35 Mn |
| Feb 28, 2023 | 25,000.00 |
| Feb 28, 2023 | 25,000.00 |
| Nov 30, 2022 | 237,000.00 |
| Nov 30, 2022 | 237,000.00 |
| Aug 31, 2022 | 1.78 Mn |
| Aug 31, 2022 | 1.78 Mn |
| May 31, 2022 | 37,665.00 |
| May 31, 2022 | 37,665.00 |